Preambolo 1
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC ( 1 ) , and in particular Article 13(2) thereof,
Whereas:
HAS ADOPTED THIS REGULATION:
recital 1recital 1
(1) GlenBiotech submitted to the rapporteur Member State, the Netherlands, on 10 March 2017 an application pursuant to Article 7(1) of Regulation (EC) No 1107/2009 for the approval of the active substance Beauveria bassiana strain 203.
recital 2recital 2
(2) In accordance with Article 9(3) of Regulation (EC) No 1107/2009, the rapporteur Member State, notified the applicant, the other Member States, the Commission and the European Food Safety Authority (‘the Authority’) of the admissibility of the application on 20 July 2017.
recital 3recital 3
(3) For that active substance, the effects on human and animal health and the environment have been assessed, pursuant to Article 11(2) and (3) of Regulation (EC) No 1107/2009, for the use proposed by the applicant. On 5 June 2019, the rapporteur Member State submitted a draft assessment report to the Commission with a copy to the Authority, concluding that the active substance can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
recital 4recital 4
(4) In accordance with Article 12(1) of Regulation (EC) No 1107/2009 the Authority circulated the draft assessment report received from the rapporteur Member State to the applicant and the other Member States and organised a public consultation on it.
recital 5recital 5
(5) In accordance with Article 12(3) of Regulation (EC) No 1107/2009, the Authority requested the applicant to submit additional information to the Member States, the Commission and the Authority. The rapporteur Member State assessed the additional information and submitted its assessment to the Authority in the form of an updated draft assessment report in July 2020.
recital 6recital 6
(6) On 6 October 2020, the Authority communicated to the applicant, the Member States and the Commission its conclusion ( 2 ) on whether the active substance Beauveria bassiana strain 203 can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009. The Authority made its conclusion available to the public.
recital 7recital 7
(7) On 22 October 2021, the Commission presented to the Standing Committee on Plants, Animals, Food and Feed a review report and the draft of this Regulation providing that Beauveria bassiana strain 203 is approved.
recital 8recital 8
(8) The applicant was given the possibility to submit comments on the review report.
recital 9recital 9
(9) The Commission considers that, based on the draft assessment report from the rapporteur Member State, the conclusions from the Authority and the comments from the applicant, with respect to the representative use of at least one plant protection product containing Beauveria bassiana 203 which was examined and is detailed in the review report, that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied. It is therefore appropriate to approve Beauveria bassiana strain 203.
recital 10recital 10
(10) In accordance with Article 13(2) of Regulation (EC) No 1107/2009 in conjunction with Article 6 (b), (c) and (e) thereof and in the light of current scientific and technical knowledge, it is, however, necessary to include certain conditions and restrictions, these are, the maximum content of the metabolite of concern beauvericin in plant protection products, as well as the restriction of use to ornamental palm trees.
recital 11recital 11
(11) In accordance with Article 13(4) of Regulation (EC) No 1107/2009, the Annex to Commission Implementing Regulation (EU) No 540/2011 ( 3 ) should be amended accordingly.
recital 12recital 12
(12) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
Articolo 1Approval of the active substance
The active substance Beauveria bassiana strain 203, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Articolo 2Amendments to Implementing Regulation (EU) No 540/2011
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.
Articolo 3Entry into force
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
Allegato IANNEX I
Common Name, Identification Numbers IUPAC Name Purity ( 1 ) Date of approval Expiration of approval Specific provisions Beauveria bassiana strain 203 Accession number at Centraal Bureau voor Schimmelcultures (Fungal Biodiversity Centre, Institute of the Royal Netherlands Academy of Arts and Sciences, Utrecht, Netherlands): CBS 121097 Not applicable Max. level of beauvericin: 80 μg/kg in the formulated product. 19 April 2022 18 April 2032 Only uses on ornamental palm trees shall be authorised. For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Beauveria bassiana strain 203, and in particular Appendices I and II thereto, shall be taken into account. In this overall assessment Member States shall pay particular attention to: a) the maximum level of the metabolite beauvericin in the plant protection product; b) the protection of operators and workers, taking into account that the species Beauveria basssiana , irrespective of the strain, is a potential human allergen by both skin and inhalatory exposure, and therefore ensuring that adequate personal protective equipment is included as a condition of use. Strict maintenance of environmental conditions and quality control analysis during the manufacturing process shall be assured by the producer, in order to ensure the fulfilment of the limits on microbiological contamination as referred to in the Working Document SANCO/12116/2012 ( 2 ) . Conditions of use shall include risk mitigation measures, where appropriate.
Allegato IIANNEX II
In Part B of the Annex to Implementing Regulation (EU) No 540/2011, the following entry is added:
‘151 Beauveria bassiana strain 203 Accession number at Centraal Bureau voor Schimmelcultures (Fungal Biodiversity Centre, Institute of the Royal Netherlands Academy of Arts and Sciences, Utrecht, Netherlands): CBS 121097 Not applicable Max. level of beauvericin: 80 μg/kg in the formulated product. 19 April 2022 18 April 2032 Only uses on ornamental palm trees shall be authorised. For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Beauveria bassiana strain 203, and in particular Appendices I and II thereto, shall be taken into account. In this overall assessment Member States shall pay particular attention to: a) the maximum level of the metabolite beauvericin in the plant protection product; b) the protection of operators and workers, taking into account that the species Beauveria basssiana , irrespective of the strain, is a potential human allergen by both skin and inhalatory exposure, and therefore ensuring that adequate personal protective equipment is included as a condition of use. Strict maintenance of environmental conditions and quality control analysis during the manufacturing process shall be assured by the producer, in order to ensure the fulfilment of the limits on microbiological contamination as referred to in the Working Document SANCO/12116/2012 ( *1 ) . Conditions of use shall include risk mitigation measures, where appropriate.